BiovelocITA
Entry
2015
Hold
11yr
Status
Active
Who owns BiovelocITA?
BiovelocITA is an Italian Biotech company, currently owned by Indaco Venture Partners SGR since 2016 and Sofinnova Partners.
Hand-verified · updated 2026-09-30
Open JSON · CC-BYMost recent investor
Sofinnova PartnersSofinnova Capital VIII · 2015 · Life Sciences VC
2 ownership periods · full history below
Key facts
HQItaly
SectorBiotech
Ownership history
2 ownership periods · co-invest detected
Active
Co-invest · 2 holders · 2015 · present
Sofinnova PartnersActive
2015 · present(11yr) · Sofinnova Capital VIII · 2015 · Life Sciences VC
More from Sofinnova Capital VIII
Other portfolio companies in the same fund.
VectivBio
Exited 2023
Biotech
Switzerland· 2017
to Ironwood Pharmaceuticals
Breath Therapeutics
Exited 2019
Biotech
Germany· 2016
to Zambon
Corvidia Therapeutics
Exited 2020
Biotech
US· 2016
to Novo Nordisk
Delinia
Exited 2017
Biotech
UK· 2016
to Celgene
ENYO Pharma
Active
Biotech
France· 2016
ReCor Medical
Exited 2018
MedTech
US· 2016
to Otsuka Holdings
More PE-backed in Biotech
Comparable biotech deals from other GPs.
Questions
Who owns BiovelocITA?
BiovelocITA is currently owned by Indaco Venture Partners SGR and Sofinnova Partners, through Sofinnova Capital VIII, since 2016.
When did Indaco Venture Partners SGR and 1 other acquire BiovelocITA?
Indaco Venture Partners SGR and 1 other acquired BiovelocITA in 2016.
Who has owned BiovelocITA over time?
BiovelocITA has been through 2 private-equity ownership periods: Sofinnova Partners · via Sofinnova Capital VIII · since 2015; Indaco Venture Partners SGR · via Atlante Seed · since 2016.
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue